Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia

Blood

Volumn 88, Issue 1, 1996, Pages 353-357

  Bacigalupo, A ^a   Van Lint, M T ^a   Valbonesi, M ^a   Lercari, G ^a   Carlier, P ^a   Lamparelli, T ^a   Gualandi, F ^a   Occhini, D ^a   Bregante, S ^a   Valeriani, A ^a   Piaggio, G ^a   Pitto, A ^a   Benvenuto, F ^a   Figari, O ^a   De Stefano, G ^a   Caimo, A ^a   Sessarego, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; THIOTEPA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT GM; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKAPHERESIS; LEUKEMIA; LIVER FAILURE; LYMPHOMA; MALE; MORTALITY; MULTIPLE MYELOMA; MULTIPLE ORGAN FAILURE; MYELODYSPLASIA; MYELOFIBROSIS; PRIORITY JOURNAL; SEPSIS; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 8944228466     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.1.353.bloodjournal881353     Document Type: Article

References (25)

1. Torres A, Alonso MC, Gomez-Villagran JL, Manzanares MR, Martinez F, Gomez P, Garcia JM, Andres P, Gomez C, Torre MA, Velasco F: No influence of number of donor CFU-GM on granulocyte recovery in bone marrow transplantation for acute leukemia. Blut 50:89, 1985
2. Atkinson K, Norrie S, Chan P, Downs K, Biggs J: Lack of correlation between nucleated bone marrow cell dose, marrow CFU-GM dose or marrow CFU-E dose and the rate of HLA-identical sibling marrow engraftment. Br J Hematol 60:245, 1985
3. Messner HA, Curtis JE, Minden MD, Tritchler D, Lockwood G, Takahashi T, Lepine J, Jamal N, Tweeddale M, Wandl U: Clonogenic hemopoietic precursors in bone marrow transplantation. Blood 70:1425, 1987
4. Spitzer G, Verma DS, Fisher R, Zander A, Vellekoop L, Litam J, McCredie KB, Dicke KA: The myeloid progenitor cell - its value in predicting hematopoietic recovery after autologous bone marrow transplantation. Blood 55:317, 1980
5. Arnold R, Schmeiser T, Heit W, Frickhofen N, Pabst G, Heimpel H, Kabanek B: Hematopoietic reconstitution after bone marrow transplantation. Exp Hematol 14:271, 1986
6. Douay L, Gorin NC, Mary JY, Lamarie E, Lopez M, Najman A, Stachoviak J, Giarratana MC, Baillou C, Salmon C: Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol 14:358, 1986
7. Rowley SD, Zuheidorf M, Braine HG, Colvin OM, Davis J, Jones RJ, Saral R, Sensenbrenner LL, Yeager A, Santos GW: CFU-GM content of bone marrow graft correlates with time to hematopoietic reconstitution following autologous bone marrow transplantation with 4 hydroperoxycyclophosphamide. Blood 70:271, 1987
8. Bacigalupo A, Piaggio G, Podesta' M, Figari O, Benvenuto F, Sogno G, Tedone E, Raffo MR, Grassia L, Ferrero R, Van Lint MT, Gualandi F: Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation. Bone Marrow Transplant 15:221, 1995
9. Bacigalupo A, Tong J, Podesta' M, Piaggio G, Figari O, Colombo P, Sogno G, Tedone E, Moro F, Van Lint MT, Frassoni F, Occhini D, Gualandi F, Lamparelli T, Marmont AM: Bone marrow harvest for marrow transplantation: Effect of multiple small (2 ml) or large (20 ml) aspirates. Bone Marrow Transplant 9:467, 1992
10. Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM: Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74:1905, 1989
11. Weaver CH, Buckner CD, Longin K, et al: Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 82:1981, 1993
12. Kessinger A, Smith DM, Strandjord SE, Landmark JD, Dooley DC, Law P, Coccia PF, Warketin PI, Weisenburg DD, Armitage JO: Allogeneic transplantation of blood derived T-cell depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 4:643, 646, 1989
13. Dreger P, Suttorp M, Haferiach T, Loffler H, Schmitz N: Alogeneic franulocyte colony-stimulating factor mobilized peripheral blood progenitors cells for treatment of engraftment failure after bone marrow transplantation. Blood 81:1404, 1409, 1993
14. Ringdén O, Ruutu T, Remberger M, Nikoskelainen J, Volin S, Vindelov L, Parkkali T, Lemhoff S, Sallerfors B, Ljiungman P, Mellander L, Jacobsen N for the Nordi Bone Marrow Transplanta-tion Group: A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplantation Group. Blood 83:2723, 1994
15. Terenzi A, Lubin I, Lapidot T, Salomon O, Faktorowich Y, Rabi I, Martelli MF, Reisner Y: Enhancement of T-cell depleted bone marrow allografts in mice by thiotepa. Transplantation 50:71, 1990
16. Eder JP, Antman K, Elias A, Shea TC, Teicher B, Henner WD, Schryber SM, Holden S, Finberg R, Chritchlow J, Flaherty M, Mick R, Schnipper LE, Frei E: Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors. J Natl Cancer Inst 80:1221, 1988
17. Kaplan EL, Meier P: Non parametric estimation for incomplete observations. J Am Stat Assoc 53:457, 1958
18. Majolino I, Aversa F, Bacigalupo A, Bandini G, Arcese W, Reali G, for GITMO: Allogeneic transplants rhG-CSF-mobilized peripheral blood stem cells (PBSC) from normal donors. Haematologica 80:40, 1995
19. Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannoni C, Iacucci R, Zei T, Martelli MP, Gambelunghe C, Rosetti M, Caputo P, Latini P, Aristei C, Raymondi C, Reisner Y, Martelli MF: Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84:3948, 3955, 1994
20. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Loffler H, Muller-Rucholtz W, Schmitz N: G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft. Br J Haematol 87:609, 1994
21. Besinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 15:1655, 1995
22. Korbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allograft. Blood 15:1659, 1995
23. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Loffer H, Hunter A, Russel NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgrastim (granulocyte-colony-stimulating factor). Blood 15:1666, 1995
24. Majolino I, Saglio G, Scime' R, Serra A, Cavallaro AM, Fiandaca T, Vasta S, Pampinella M, Marceno' R, Santoro A: High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell (PBSC) transplanlation in patients with hematologic malignancies. Blood 86:108, 1995 (abstr, suppl 1)
25. Anderlini P, Przepiorka D, Khouri I, van Besien K, Mehra R, Giralt S, Gajewski J, Cleary K, Champlin R, Andersson B, Korbling M: Chronic graft-vs-host disease (GVHD) after allogeneic marrow or blood stem cell transplantation. Blood 1995 (abstr, suppl 1)